|
1
|
May AL, Kuklina EV and Yoon PW: Prevalence
of cardiovascular disease risk factors among US adolescents,
1999–2008. Pediatrics. 129:1035–1041. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McBean AM, Li S, Gilbertson DT and Collins
AJ: Differences in diabetes prevalence, incidence, and mortality
among the elderly of four racial/ethnic groups: Whites, blacks,
hispanics, and asians. Diabetes Care. 27:2317–2324. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Onkamo P, Väänänen S, Karvonen M and
Tuomilehto J: Worldwide increase in incidence of Type I diabetes -
the analysis of the data on published incidence trends.
Diabetologia. 42:1395–1403. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patterson C, Guariguata L, Dahlquist G,
Soltész G, Ogle G and Silink M: Diabetes in the young - a global
view and worldwide estimates of numbers of children with type 1
diabetes. Diabetes Res Clin Pract. 103:161–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Klöppel G, Löhr M, Habich K, Oberholzer M
and Heitz PU: Islet pathology and the pathogenesis of type 1 and
type 2 diabetes mellitus revisited. Surv Synth Pathol Res.
4:110–125. 1985.PubMed/NCBI
|
|
6
|
Zammitt NN and Frier BM: Hypoglycemia in
type 2 diabetes: Pathophysiology, frequency, and effects of
different treatment modalities. Diabetes Care. 28:2948–2961. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hannon TS, Rao G and Arslanian SA:
Childhood obesity and type 2 diabetes mellitus. Pediatrics.
116:473–480. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ogden CL, Flegal KM, Carroll MD and
Johnson CL: Prevalence and trends in overweight among US children
and adolescents, 1999–2000. JAMA. 288:1728–1732. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tuomilehto J, Zimmet P, Mackay IR, Koskela
P, Vidgren G, Toivanen L, Tuomilehto-Wolf E, Kohtamäki K, Stengård
J and Rowley MJ: Antibodies to glutamic acid decarboxylase as
predictors of insulin-dependent diabetes mellitus before clinical
onset of disease. Lancet. 343:1383–1385. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Association AD: American Diabetes
Association: Type 2 diabetes in children and adolescents.
Pediatrics. 105:671–680. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Scheen AJ: Clinical pharmacokinetics of
metformin. Clin Pharmacokinet. 30:359–371. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aronoff SL, Berkowitz K, Shreiner B and
Want L: Glucose metabolism and regulation: beyond insulin and
glucagon. Diab Spectr. 17:183–190. 2004. View Article : Google Scholar
|
|
13
|
Miles HL and Acerini CL: Insulin analog
preparations and their use in children and adolescents with type 1
diabetes mellitus. Paediatr Drugs. 10:163–176. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Davidson MB, Castellanos M, Kain D and
Duran P: The effect of self monitoring of blood glucose
concentrations on glycated hemoglobin levels in diabetic patients
not taking insulin: a blinded, randomized trial. Am J Med.
118:422–425. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ludwig DS and Ebbeling CB: Type 2 diabetes
mellitus in children: primary care and public health
considerations. JAMA. 286:1427–1430. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Patel A, MacMahon S, Chalmers J, Billot L,
Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P and
Harrap S: Intensive blood glucose control and vascular outcomes in
patients with type 2 diabetes. N Engl J Med. 358:2560–2572. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carino GP and Mathiowitz E: Oral insulin
delivery. Adv Drug Deliv Rev. 35:249–257. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gutniak M, Ørkov C, Holst JJ, Ahrén B and
Efendić S: Antidiabetogenic effect of glucagon-like peptide-1
(7–36) amide in normal subjects and patients with diabetes
mellitus. N Engl J Med. 326:1316–1322. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Diabetes Prevention Program Research
Group. Reduction in the incidence of type 2 diabetes with lifestyle
intervention or metformin. N Engl J Med. 346:393–403. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goran MI, Bergman RN, Avila Q, Watkins M,
Ball GD, Shaibi GQ, Weigensberg MJ and Cruz ML: Impaired glucose
tolerance and reduced β-cell function in overweight Latino children
with a positive family history for type 2 diabetes. J Clin
Endocrinol Metab. 89:207–212. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jones KL, Arslanian S, Peterokova VA, Park
JS and Tomlinson MJ: Effect of metformin in pediatric patients with
type 2 diabetes: A randomized controlled trial. Diabetes Care.
25:89–94. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ehtisham S, Barrett TG and Shaw NJ: Type 2
diabetes mellitus in UK children - an emerging problem. Diabet Med.
17:867–871. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bandyopadhyay GK, Yu JG, Ofrecio J and
Olefsky JM: Increased malonyl-CoA levels in muscle from obese and
type 2 diabetic subjects lead to decreased fatty acid oxidation and
increased lipogenesis; thiazolidinedione treatment reverses these
defects. Diabetes. 55:2277–2285. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pearson ER, Flechtner I, Njølstad PR,
Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E,
Iotova V, et al: Neonatal Diabetes International Collaborative
Group: Switching from insulin to oral sulfonylureas in patients
with diabetes due to Kir6.2 mutations. N Engl J Med. 355:467–477.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krentz AJ and Bailey CJ: Oral antidiabetic
agents: Current role in type 2 diabetes mellitus. Drugs.
65:385–411. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Atkinson MA and Eisenbarth GS: Type 1
diabetes: New perspectives on disease pathogenesis and treatment.
Lancet. 358:221–229. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shapiro AM, Lakey JR, Ryan EA, Korbutt GS,
Toth E, Warnock GL, Kneteman NM and Rajotte RV: Islet
transplantation in seven patients with type 1 diabetes mellitus
using a glucocorticoid-free immunosuppressive regimen. N Engl J
Med. 343:230–238. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tuomilehto J, Lindström J, Eriksson JG,
Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S,
Laakso M, Louheranta A, Rastas M, et al: Finnish Diabetes
Prevention Study Group: Prevention of type 2 diabetes mellitus by
changes in lifestyle among subjects with impaired glucose
tolerance. N Engl J Med. 344:1343–1350. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sone H, Katagiri A, Ishibashi S, Abe R,
Saito Y, Murase T, Yamashita H, Yajima Y, Ito H, Ohashi Y, et al:
Effects of lifestyle modifications on patients with type 2
diabetes: the Japan Diabetes Complications Study (JDCS) study
design, baseline analysis and three year-interim report. Horm Metab
Res. 34:509–515. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fioretto P, Steffes MW, Sutherland DE,
Goetz FC and Mauer M: Reversal of lesions of diabetic nephropathy
after pancreas transplantation. N Engl J Med. 339:69–75. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Onge ES, Miller SA, Motycka C and DeBerry
A: A review of the treatment of type 2 diabetes in children. J
Pediatr Pharmacol Ther. 20:4–16. 2015.PubMed/NCBI
|
